Wenlong Li1, Jing Xu, Xiaojian Wang, Jingzhou Chen, Channa Zhang, Kai Sun, Rutai Hui. 1. Key Laboratory for Clinical Cardiovascular Genetics, Ministry of Education, Sino-German Laboratory for Molecular Medicine, Cardiovascular Institute, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, 167 Beilishi Road, Beijing 100037, PR China.
Abstract
OBJECTIVE: Previous case-control studies suggested the single nucleotide polymorphisms of lymphotoxin-alpha (LTA) gene and galectin-2 (LGASL2) gene are associated with coronary artery disease and myocardial infarction. However, other studies did not confirm this relationship. The objective was to assess the relationship of LTA gene, LGALS2 gene and coronary artery disease, using a meta-analysis. METHODS: Databases, including PubMed, EMbase, CBM and CNKI, were searched to get the genetic association studies. Data were extracted by two authors and pooled odds ratio (OR) and 95% confidence interval (CI) were calculated. RESULT: The meta-analysis included 20640 (LTA-A252G) and 10552 (LGALS2-C3279T) cases, 15388 (A252G) and 10545 (C3279T) controls. The pooled OR of 252G was 1.02 (95%CI: 0.97-1.07) compared to wild type allele in dominant model, and was 1.00 (95%CI: 0.94-1.07) in recessive model. The pooled OR of 3279T was 0.95 (95%CI: 0.89-1.01) compared to wild type allele in dominant model, and was 0.89 (95%CI: 0.78-1.00) in recessive model. None of the polymorphisms was found to associate with coronary artery disease. CONCLUSION: In present study, the LTA gene and LGALS2-C3279T are not associated with coronary artery disease. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
OBJECTIVE: Previous case-control studies suggested the single nucleotide polymorphisms of lymphotoxin-alpha (LTA) gene and galectin-2 (LGASL2) gene are associated with coronary artery disease and myocardial infarction. However, other studies did not confirm this relationship. The objective was to assess the relationship of LTA gene, LGALS2 gene and coronary artery disease, using a meta-analysis. METHODS: Databases, including PubMed, EMbase, CBM and CNKI, were searched to get the genetic association studies. Data were extracted by two authors and pooled odds ratio (OR) and 95% confidence interval (CI) were calculated. RESULT: The meta-analysis included 20640 (LTA-A252G) and 10552 (LGALS2-C3279T) cases, 15388 (A252G) and 10545 (C3279T) controls. The pooled OR of 252G was 1.02 (95%CI: 0.97-1.07) compared to wild type allele in dominant model, and was 1.00 (95%CI: 0.94-1.07) in recessive model. The pooled OR of 3279T was 0.95 (95%CI: 0.89-1.01) compared to wild type allele in dominant model, and was 0.89 (95%CI: 0.78-1.00) in recessive model. None of the polymorphisms was found to associate with coronary artery disease. CONCLUSION: In present study, the LTA gene and LGALS2-C3279T are not associated with coronary artery disease. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
Authors: Jan Máchal; Monika Pávková-Goldbergová; Ota Hlinomaz; Ladislav Groch; Anna Vašků Journal: Medicine (Baltimore) Date: 2014-12 Impact factor: 1.889
Authors: Shaomin Qian; April Hoggatt; Yava L Jones-Hall; Carl F Ware; Paul Herring; Cheikh I Seye Journal: Vascul Pharmacol Date: 2016-06-26 Impact factor: 5.773
Authors: Ignacio M Seropian; Germán E González; Sebastián M Maller; Daniel H Berrocal; Antonio Abbate; Gabriel A Rabinovich Journal: Mediators Inflamm Date: 2018-11-05 Impact factor: 4.711
Authors: Antonio P Mansur; Julio Y Takada; Célia M C Strunz; Solange D Avakian; Luiz Antonio M César; José A F Ramires Journal: Clinics (Sao Paulo) Date: 2013-12 Impact factor: 2.365